These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16362643)

  • 1. Viral reactivation and pseudotype production in an in vitro superinfection system with two different strains of HIV-1.
    Fernández Larrosa PN; Ceballos A; Andreani G; Marquina S; Martínez Peralta L; Rabinovich RD
    Arch Virol; 2006 Apr; 151(4):651-62. PubMed ID: 16362643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different integrated and unintegrated HIV-1 DNA after superinfection and cell to cell transmission.
    Marquina S; Libonatti O; Ceballos A; Gómez Carrillo M; Martínez Peralta L; Rabinovich RD
    Acta Physiol Pharmacol Ther Latinoam; 1997; 47(4):245-50. PubMed ID: 9504185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-depth analysis of a heterosexually acquired human immunodeficiency virus type 1 superinfection: evolution, temporal fluctuation, and intercompartment dynamics from the seronegative window period through 30 months postinfection.
    McCutchan FE; Hoelscher M; Tovanabutra S; Piyasirisilp S; Sanders-Buell E; Ramos G; Jagodzinski L; Polonis V; Maboko L; Mmbando D; Hoffmann O; Riedner G; von Sonnenburg F; Robb M; Birx DL
    J Virol; 2005 Sep; 79(18):11693-704. PubMed ID: 16140747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of neutralizing antibody response to HIV-1 predisposes to superinfection.
    Smith DM; Strain MC; Frost SD; Pillai SK; Wong JK; Wrin T; Liu Y; Petropolous CJ; Daar ES; Little SJ; Richman DD
    Virology; 2006 Nov; 355(1):1-5. PubMed ID: 16962152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 superinfection in an HIV-2-infected woman with subsequent control of HIV-1 plasma viremia.
    Günthard HF; Huber M; Kuster H; Shah C; Schüpbach J; Trkola A; Böni J
    Clin Infect Dis; 2009 Jun; 48(11):e117-20. PubMed ID: 19382874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of viral evolution and neutralizing antibody response after HIV-1 superinfection.
    Chaillon A; Wagner GA; Hepler NL; Little SJ; Kosakovsky Pond SL; Caballero G; Pacold ME; Phung P; Wrin T; Richman DD; Wertheim JO; Smith DM
    J Virol; 2013 Dec; 87(23):12737-44. PubMed ID: 24049166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HSV-2- and HIV-1- permissive cell lines co-infected by HSV-2 and HIV-1 co-replicate HSV-2 and HIV-1 without production of HSV-2/HIV-1 pseudotype particles.
    Legoff J; Bouhlal H; Lecerf M; Klein C; Hocini H; Si-Mohamed A; Muggeridge M; Bélec L
    Virol J; 2007 Jan; 4():2. PubMed ID: 17207276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latent HIV-1 can be reactivated by cellular superinfection in a Tat-dependent manner, which can lead to the emergence of multidrug-resistant recombinant viruses.
    Donahue DA; Bastarache SM; Sloan RD; Wainberg MA
    J Virol; 2013 Sep; 87(17):9620-32. PubMed ID: 23804632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV superinfection in women may boost immune response.
    Rose S
    Expert Rev Anti Infect Ther; 2012 May; 10(5):525. PubMed ID: 22702314
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombination in HIV: an important viral evolutionary strategy.
    Burke DS
    Emerg Infect Dis; 1997; 3(3):253-9. PubMed ID: 9284369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-dependent cell-mediated virus inhibition antibody activity does not correlate with risk of HIV-1 superinfection.
    Forthal DN; Landucci G; Chohan B; Richardson BA; McClelland RS; Jaoko W; Blish C; Overbaugh J
    J Acquir Immune Defic Syndr; 2013 May; 63(1):31-3. PubMed ID: 23344546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Superinfection Resembles Primary Infection.
    Sheward DJ; Ntale R; Garrett NJ; Woodman ZL; Abdool Karim SS; Williamson C
    J Infect Dis; 2015 Sep; 212(6):904-8. PubMed ID: 25754982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting antibody responses to intrasubtype superinfection with CRF02_AG.
    Courtney CR; Mayr L; Nanfack AJ; Banin AN; Tuen M; Pan R; Jiang X; Kong XP; Kirkpatrick AR; Bruno D; Martens CA; Sykora L; Porcella SF; Redd AD; Quinn TC; Nyambi PN; Dürr R
    PLoS One; 2017; 12(3):e0173705. PubMed ID: 28288209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 intra-subtype superinfection rates: estimates using a structured coalescent with recombination.
    Taylor JE; Korber BT
    Infect Genet Evol; 2005 Jan; 5(1):85-95. PubMed ID: 15567142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug induced superinfection in HIV and the evolution of drug resistance.
    Leontiev VV; Maury WJ; Hadany L
    Infect Genet Evol; 2008 Jan; 8(1):40-50. PubMed ID: 18024234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superinfection of human immunodeficiency virus type 1 (HIV-1) to cell clone persistently infected with defective virus induces production of highly cytopathogenic HIV-1.
    Iwabu Y; Goto T; Tsuji S; Warachit J; Li GM; Shoji S; Kameoka M; Ikuta K
    Microbes Infect; 2006 Jun; 8(7):1773-82. PubMed ID: 16815724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the Neutralizing Antibody Response in a Case of Genetically Linked HIV Superinfection.
    Ssemwanga D; Doria-Rose NA; Redd AD; Shiakolas AR; Longosz AF; Nsubuga RN; Mayanja BN; Asiki G; Seeley J; Kamali A; Ransier A; Darko S; Walker MP; Bruno D; Martens C; Douek D; Porcella SF; Quinn TC; Mascola JR; Kaleebu P
    J Infect Dis; 2018 Apr; 217(10):1530-1534. PubMed ID: 29579256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells.
    Massanella M; Puigdomènech I; Cabrera C; Fernandez-Figueras MT; Aucher A; Gaibelet G; Hudrisier D; García E; Bofill M; Clotet B; Blanco J
    AIDS; 2009 Jan; 23(2):183-8. PubMed ID: 19098487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus chronically infected human T lymphocytes are susceptible to HIV-1 superinfection and support HIV-1 pseudotyping.
    Calistri A; Parolin C; Pizzato M; Calvi P; Giaretta I; Palù G
    J Acquir Immune Defic Syndr; 1999 Jun; 21(2):90-8. PubMed ID: 10360799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus (HIV) type 1 can superinfect HIV-2-infected cells: pseudotype virions produced with expanded cellular host range.
    Le Guern M; Levy JA
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):363-7. PubMed ID: 1346069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.